Blood Test Shows Promise for Tailoring Colon Cancer Chemotherapy
Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.
Category: Cancer
Cancer
Latest
Cancer
Latest
Samsung Invests $110M in GRAIL to Expand Cancer Detection Test in Asia
Partnership will bring Galleri multi-cancer early detection test to South Korea, with potential expansion to Japan and Singapore.
Cancer
Latest
AI-Powered Blood Test Shows Promise for Early Lung Cancer Detection
A new blood-based test that combines four protein markers with artificial intelligence has demonstrated potential for early lung cancer detection in a multicenter retrospective study.
Clinical Study to Evaluate ctDNA Test for Guiding Lung Cancer Treatment
Haystack Oncology and Rutgers Cancer Institute collaborate on phase II trial examining minimal residual disease testing in stage II/III NSCLC patients.
Read More
Investigational AI Tool Cuts Acute Leukemia Diagnosis Time to Two Hours
MARLIN uses DNA methylation patterns and machine learning to classify leukemia subtypes, potentially accelerating treatment decisions.
Read More
FDA OKs Cartridge-Based Companion Diagnostic Test for Colorectal Cancer
The test provides fully automated, sample-to-result testing to identify patients eligible for immunotherapy treatment.
Read More
Circulating Tumor DNA Shows Promise for Guiding Immunotherapy in Lung Cancer
Study of 177 patients with limited-stage small cell lung cancer demonstrates ctDNA’s potential to personalize consolidation immunotherapy decisions.
Read More
Genomic Test Shows Promise for Guiding Chemotherapy Decisions in Metastatic Prostate Cancer
Phase 3 STAMPEDE trial data demonstrates Decipher Prostate test can predict docetaxel treatment benefit, potentially helping patients avoid unnecessary toxicity.
Read More
Personalis MRD Test Shows Superior Sensitivity in Lung Cancer Trial
The test demonstrated higher baseline sensitivity for ctDNA detection compared to gene mutation-based testing in AstraZeneca’s NeoADAURA study.
Read More
Cerebrospinal Fluid Test Identifies Brain Cancers with 100% Specificity
Johns Hopkins researchers develop multi-analyte assay combining tumor DNA, mutations, and immune cell signatures for central nervous system cancer diagnosis.
Read More
FDA Grants De Novo Authorization for AI-Powered Prostate Cancer Prognostic Software
The risk stratification tool is designed to predict long-term outcomes for patients with non-metastatic prostate cancer.
Read More
VieCure Adds Summit Cancer Centers to Community Oncology Network
Multi-disciplinary cancer center will implement Halo Intelligence platform to enhance precision oncology capabilities across Pacific Northwest.
Read More
Ultrasensitive MRD Test Shows Greater Prognostic Accuracy Than PET/CT in Lymphoma
Pooled analysis of 137 patients shows the assay achieved 86% sensitivity and 91% specificity for relapse detection in large B-cell lymphoma, leading to NCCN guideline inclusion.
Read More
Blood Test Achieves 85% Accuracy in Predicting Breast Cancer Immunotherapy Response
Researchers develop PIPscore using plasma proteomics to identify triple-negative breast cancer patients most likely to benefit from immunotherapy treatment.
Read More
Mass General Brigham Launches Trials of Blood Test to Guide Post-Surgery Cancer Care
Two studies will evaluate circulating tumor DNA as a guide for post-surgical cancer treatment decisions.
Read More
Colorectal Cancer Screening Surges 62% Among Adults 45-49, Driving Early-Stage Diagnoses
Two new American Cancer Society studies reveal significant increases in colorectal cancer...
Read More
Three Boston Institutions Launch Precision Genomics Initiative for Pediatric Cancer Testing
Dana-Farber Cancer Institute, Boston Children’s Hospital, and Broad Clinical Labs form BrightSeq collaborative to develop novel clinical diagnostic assays for rare pediatric cancers.
Read More
At-Home Cervical Cancer Screening Now Available, Starting in California
This marks the first time a US Food and Drug Adminstration-authorized self-collection device is available for at-home cervical cancer screening in the US.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- ...
- 186